Back to Search
Start Over
The Efficacy and Safety of Direct-acting Antiviral Treatment for Chronic Hepatitis C Patients: A Single Center Study
- Source :
- The Korean Journal of Gastroenterology, Vol 72, Iss 4, Pp 197-204 (2018)
- Publication Year :
- 2018
- Publisher :
- Jin Publishing & Printing Co., 2018.
-
Abstract
- Background /Aims: Direct-acting antiviral (DAA) therapy has been shown to achieve a high rate of sustained virologic response (SVR) and favorable outcomes in chronic hepatitis C (CHC) patients. We investigated the virologic response and its clinical impact in CHC patients. Methods : CHC patients with compensated liver function treated with DAAs between 2016 and 2017 were included for retrospective analysis. We analyzed baseline characteristics and virologic and biochemical responses at on-treatment 4 weeks, end of treatment, and post-treatment 12 weeks. Fibrosis was measured as liver stiffness measurement by transient elastography (FibroScan). Adverse events were monitored during the treatment period. Results : A total of 135 patients (61.5% with genotype [GT] 1b and 38.5% with GT 2a) were enrolled 47.4% were male, 79.3% were treatment naive, and 30.4% had cirrhosis. SVR 12 was observed in 97.6% (81/83) in the GT 1b and 98.1% (51/52) in the GT 2a; treatment with daclatasvir+asunaprevir was the most commonly used in GT 1b (55/83), and sofosbuvir+ribavirin was the most commonly used in GT 2a (49/52). The median change of liver stiffness measurement at two time points using the signed rank test was -3.2 kPa in patients who underwent transient elastography before treatment and at SVR 12 (n=25). The most common adverse events were anemia, dyspepsia, and insomnia. One GT 2a patient treated with sofosbuvir+ribavirin stopped the treatment at 8 weeks due to symptomatic bradyarrhythmia; however, he recovered spontaneously and achieved SVR 12. Conclusion s: DAA treatment of chronic hepatitis C genotype 1b and 2a resulted in a high rate of sustained virologic response and improvement of liver fibrosis score.
- Subjects :
- Hepatitis C
chronic
Antiviral agents
Sustained virologic response
Medicine
Subjects
Details
- Language :
- English, Korean
- ISSN :
- 15989992
- Volume :
- 72
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- The Korean Journal of Gastroenterology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.680d6c38f7d42bca36ab16fea251471
- Document Type :
- article
- Full Text :
- https://doi.org/10.4166/kjg.2018.72.4.197